# Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes

> **NCT04852029** · NA · TERMINATED · sponsor: **Reproductive Medicine Associates of New Jersey** · enrollment: 12 (actual)

## Conditions studied

- Infertility, Female

## Interventions

- **OTHER:** Low dose hCG

## Key facts

- **NCT ID:** NCT04852029
- **Lead sponsor:** Reproductive Medicine Associates of New Jersey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-16
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** recruitment issues
- **Last updated:** 2022-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04852029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04852029, "Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04852029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*